ADHD does not always end with childhood: according to two large estimates, it affects about 2.6 to 2.8% of adults worldwide. In adults it mainly shows up as difficulties with attention, organisation, impulsivity and managing emotions, which weigh on work, money and relationships. It can be diagnosed at any age, and several treatments have proven benefits in adults, with real effects that are more modest than is often claimed.
- Persistence: about 15% of children with ADHD still meet full criteria at age 25, about 65% if partial forms are counted.
- Co-occurring conditions: one adult with ADHD in two has had another mental health condition in the past year, mostly anxiety or mood disorders.
- Treatment: medication reduces symptoms in the short term, with an effect that is mostly medium in size; cognitive behavioural therapy may help, but the evidence is of low quality.
What is ADHD in adults?
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition: it starts in childhood. Under the American Psychiatric Association's diagnostic manual (DSM-5), from age 17 a diagnosis requires:
- at least 5 of the 9 symptoms of inattention, and/or 5 of the 9 symptoms of hyperactivity-impulsivity (6 under age 17), for at least 6 months;
- several symptoms present before age 12;
- difficulties in at least two settings (work, home, friends or family);
- clear interference with social, educational or work functioning;
- symptoms not better explained by another condition (mood, anxiety, personality disorder...).
Depending on which symptoms dominate, the presentation is called inattentive, hyperactive-impulsive or combined: you can have ADHD without being visibly hyperactive.
ADHD is largely inherited (heritability is estimated at 74% in twin studies), through many genetic and environmental factors that add up. The idea of a simple "dopamine deficiency" does not hold, as explained in our article on that myth. The brain differences found are small and only hold on average: according to the 2021 international consensus statement, ADHD cannot be diagnosed by rating scales alone, neuropsychological tests or brain imaging.
How many adults have ADHD?
Two figures circulate, and they do not measure the same thing:
- 2.8%: the average of 20 World Health Organization (WHO) population surveys of 26,744 adults aged 18 to 44 (surveys carried out from 2001 to 2012, published in 2017). It ranges from 3.6% in high-income countries to 1.4% in low and lower-middle-income countries.
- 2.58% or 6.76%: a 2021 meta-analysis separates "persistent" ADHD that began in childhood (2.58%, about 140 million adults in 2020) from "symptomatic" ADHD, meaning current symptoms whatever happened in childhood (6.76%, about 366 million). The 366 million figure, sometimes wrongly attached to the 2.8%, therefore belongs to the broadest definition.
Prevalence falls with age, and persistence depends on the definition: in a 2006 meta-analysis, about 15% of children with ADHD still met full criteria at 25, about 65% when partial remission was included. The North American MTA study, which reassessed 558 children with ADHD up to about age 25, mostly found ups and downs: 63.8% went through periods of remission and recurrence, and only 9.1% showed lasting recovery.
Adult ADHD is still under-recognised: in the WHO surveys, only 3.3% of adults with ADHD had been treated for ADHD itself in the past year. Women are also diagnosed later: in the Stockholm region (85,330 people with ADHD), they were on average 23.5 years old at their first recorded diagnosis or treatment, against 19.6 for men (see our article on estrogen and ADHD). And some parents recognise themselves after their child is diagnosed (our article on these parents).
How ADHD shows up in adults
Everyone forgets an appointment or puts a task off now and then. What matters is how often it happens, whether it goes back to childhood and how much it affects several areas of life. Here are examples from the DSM-5 criteria and from the NHS (UK) page on ADHD in adults.
- Attention that drifts: trouble staying focused in a meeting, a conversation or a long document, the mind elsewhere. In adults, distractions can be unrelated thoughts.
- Organisation and time: tasks that are hard to sequence, messy work, poor time management, missed deadlines. Tasks that need sustained mental effort (reports, forms, paperwork) get avoided or put off. Researcher Russell Barkley sees this as a disorder of self-regulation: we fact-checked that idea.
- Forgetting and losing things: returning calls, paying bills, keeping appointments; keys, wallet, phone or glasses gone missing.
- Inner restlessness: in adults, hyperactivity may be limited to feeling restless, or uncomfortable staying still for long, in a restaurant or a meeting.
- Impulsivity: interrupting, finishing other people's sentences, finding it hard to wait, deciding quickly without weighing the consequences. On money, see what studies show about impulse buying.
- Emotions that are hard to regulate: irritability, mood swings, low frustration tolerance. This is not an official criterion, but a 2014 review found emotional dysregulation in 30 to 70% of adults with ADHD, mostly in clinic-based studies; population data are lacking. "Rejection sensitive dysphoria", hugely popular online, is not a validated diagnosis (our article on RSD).
- "Hyperfocus": many adults describe becoming completely absorbed in what interests them, to the point of forgetting everything else. The concept, however, is poorly defined and little studied.
The NHS also notes that ADHD is thought to be recognised less often in women, possibly because their symptoms are more often inattentive and harder to spot.
Impact and co-occurring conditions
In the WHO surveys, 51.7% of adults with ADHD had had at least one other mental health condition in the past year, including an anxiety disorder (34.2%), a mood disorder (21.9%) or an alcohol or drug use disorder (11.4%). Based on participants' recollections, ADHD usually came first. The 2021 consensus statement also lists autism, bipolar disorder and eating disorders, and points out that another condition does not rule out ADHD.
In the same surveys, 21.8% of adults with ADHD reported a marked disability in cognition (understanding and communicating) in the past month, a link partly due to co-occurring conditions; they were also more often separated, divorced or widowed. In Sweden, among 17,408 people with ADHD followed from 2006 to 2009, the risk of a serious transport accident was about 1.5 times that of people without ADHD: a relative risk, which does not say how many people actually had an accident.
Mortality is also higher on average, mainly through accidents and suicide, although the absolute risk stays low: see what two 2026 studies show. If you are having thoughts of suicide, please talk to someone now: in the US call or text 988, in the UK and Ireland call Samaritans on 116 123, elsewhere call your local emergency number.
How diagnosis works
ADHD can be diagnosed at any age: the UK guideline from NICE (NG87) covers adults, including those never diagnosed as children. According to NICE, the diagnosis should be made by a specialist psychiatrist or another appropriately qualified professional trained in ADHD, based on a full clinical and psychosocial assessment, a full developmental and psychiatric history, and reports from people who know you. It should not rest on rating scales alone. Symptoms must meet the diagnostic criteria, cause at least moderate impairment and be present in two or more important settings. The specialist also checks that something else (anxiety, depression, sleep problems, substance use) does not explain the symptoms better.
In practice, the NHS advises starting with your GP, who can refer you; waiting times range from months to years. Our article on what to do while you wait for an assessment can help. To prepare, you can fill in our adult ADHD self-assessment questionnaire (ASRS v1.1), developed with the WHO (18 questions, about 10 minutes). It is not a diagnosis. In its 2005 validation study (154 US adults), Part A (6 questions) identified 68.7% of adults with ADHD, so a low score does not rule it out.
Treatment: what trials in adults show
Medication. There are two main families: stimulants (methylphenidate, amphetamines including lisdexamfetamine) and non-stimulants (such as atomoxetine). A large network meta-analysis (Cortese et al., 2018, 133 double-blind trials, 51 of them in adults) measured their effect at about 12 weeks, rated by clinicians, as a "standardised mean difference" (about 0.5 is a medium effect, 0.8 a large one). In adults: 0.79 for amphetamines, 0.49 for methylphenidate and 0.45 for atomoxetine, smaller than in children (1.02 and 0.78 for the first two). In adults, dropouts due to side effects were more frequent than with placebo for all three.
A 2025 meta-analysis (113 trials, 14,887 adults) confirmed that stimulants and atomoxetine were the only treatments that reduced symptoms at 12 weeks on both patient-rated and clinician-rated scales. But medication did not improve quality of life in these trials, and long-term effects remain under-studied. In short trials in adults, most ADHD medicines, stimulants and non-stimulants alike, raised pulse by about 4 to 6 beats per minute and blood pressure by 1.6 to 3.1 mmHg on average (very low certainty evidence), so monitoring is recommended whatever the medicine. In the Swedish register study mentioned above, periods on medication were associated with 58% fewer serious accidents in men, with no significant association in women (an observational study, which cannot prove cause).
NICE recommends offering medication to adults whose symptoms still cause significant impairment in at least one area of life after changes to their environment have been made and reviewed, and treatment should be started by a specialist. These figures do not tell you what suits you: talk to your doctor, and never start, stop or change a treatment on your own.
Psychological therapy. Cognitive behavioural therapy (CBT) adapted for ADHD is the best studied. In a US trial of 86 adults still impaired despite medication, 12 sessions of CBT produced 53% responders, against 23% with relaxation and education, and gains held at 12 months. The 2018 Cochrane review (14 trials, 700 participants) concluded that CBT may help in the short term, on symptoms as well as anxiety and depression, but the evidence is of low quality. In the 2025 meta-analysis, CBT, mindfulness and psychoeducation improved symptoms on clinician ratings, but not on patients' own ratings. NICE suggests non-drug treatment for adults who choose not to take medication, struggle to take it, or find it ineffective or hard to tolerate, and alongside medication when difficulties remain.
Physical activity is good for health, but its effect on adult ADHD is little studied: a meta-analysis of 13 studies on a single exercise session found small immediate effects, in young people aged 10 to 13 and 18 to 24.
Living with ADHD: what is supported by evidence
- Understand the condition. Information about ADHD (psychoeducation) is part of the CBT programmes that were tested.
- One organising system. The CBT programme tested in 2010 teaches the use of a calendar and a task list, and how to break an overwhelming task into small steps.
- Handle distractions. The same programme suggests timing how long your attention holds on a task, and writing a distraction down instead of acting on it.
- Adjust your work. A quiet workspace, written instructions, help with planning: these are "reasonable adjustments" mentioned by the NHS.
- Treat what comes with ADHD. Anxiety, depression, alcohol problems or poor sleep can be treated, and raising them is part of good care.
- Do not stay alone. Patient organisations offer support; in the UK, the NHS points to charities such as ADHD UK.
Frequently asked questions
Can ADHD start in adulthood?
The criteria require symptoms before age 12, even if nobody noticed them at the time. In the MTA study, about 95% of young people without childhood ADHD who later scored above a checklist threshold were ruled out after a full assessment; when symptoms were impairing, the most common reason was heavy substance use. Late diagnosis is common; late onset remains debated.
Can you have ADHD without hyperactivity?
Yes: that is the predominantly inattentive presentation. And childhood hyperactivity can shrink to inner restlessness in adulthood.
Is adult ADHD overdiagnosed?
The WHO surveys, carried out from 2001 to 2012, mostly showed the opposite: very few adults with ADHD were treated for it. But a checklist alone overestimates cases, which is why a full assessment matters.
Do I have to take medication?
No. Treatment is decided with your doctor, based on your difficulties, your preferences and your health. Therapy, adjustments and medication can be combined.
References: American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), ADHD criteria as reproduced in Volkow ND, Swanson JM (2013). Adult Attention Deficit-Hyperactivity Disorder. New England Journal of Medicine 369(20):1935-1944. doi:10.1056/NEJMcp1212625 (clinical review) | Faraone SV, Banaschewski T, Coghill D et al. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews 128:789-818. doi:10.1016/j.neubiorev.2021.01.022 (consensus statement) | Faraone SV, Larsson H (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry 24(4):562-575. doi:10.1038/s41380-018-0070-0 (review) | Fayyad J, Sampson NA, Hwang I et al. (2017). The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. ADHD Attention Deficit and Hyperactivity Disorders 9(1):47-65. doi:10.1007/s12402-016-0208-3 (20 population surveys, 26,744 adults aged 18-44) | Song P, Zha M, Yang Q et al. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health 11:04009. doi:10.7189/jogh.11.04009 (systematic review and meta-analysis) | Faraone SV, Biederman J, Mick E (2006). The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 36(2):159-165. doi:10.1017/S003329170500471X (meta-analysis) | Sibley MH, Arnold LE, Swanson JM et al. (2022). Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry 179(2):142-151. doi:10.1176/appi.ajp.2021.21010032 (cohort, 558 children followed to about age 25) | Sibley MH, Rohde LA, Swanson JM et al. (2018). Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. American Journal of Psychiatry 175(2):140-149. doi:10.1176/appi.ajp.2017.17030298 (cohort, 239 young people without childhood ADHD) | Skoglund C, Sundström Poromaa I, Leksell D et al. (2024). Time after time: failure to identify and support females with ADHD - a Swedish population register study. Journal of Child Psychology and Psychiatry 65(6):832-844. doi:10.1111/jcpp.13920 (register study, 85,330 people with ADHD) | NHS (page reviewed 19 March 2025). ADHD in adults | NICE (2018, with later updates). Attention deficit hyperactivity disorder: diagnosis and management (NG87) | Shaw P, Stringaris A, Nigg J, Leibenluft E (2014). Emotion dysregulation in attention deficit hyperactivity disorder. American Journal of Psychiatry 171(3):276-293. doi:10.1176/appi.ajp.2013.13070966 (review with meta-analysis) | Ashinoff BK, Abu-Akel A (2021). Hyperfocus: the forgotten frontier of attention. Psychological Research 85(1):1-19. doi:10.1007/s00426-019-01245-8 (review) | Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H (2014). Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry 71(3):319-325. doi:10.1001/jamapsychiatry.2013.4174 (register study, 17,408 people with ADHD) | Kessler RC, Adler L, Ames M et al. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine 35(2):245-256. doi:10.1017/S0033291704002892 (validation study, 154 participants) | Cortese S, Adamo N, Del Giovane C et al. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5(9):727-738. doi:10.1016/S2215-0366(18)30269-4 (network meta-analysis, 133 trials) | Ostinelli EG, Schulze M, Zangani C et al. (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. Lancet Psychiatry 12(1):32-43. doi:10.1016/S2215-0366(24)00360-2 (network meta-analysis, 113 trials, 14,887 adults) | Farhat LC, Lannes A, Del Giovane C et al. (2025). Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 12(5):355-365. doi:10.1016/S2215-0366(25)00062-8 (network meta-analysis, 102 trials) | Safren SA, Sprich S, Mimiaga MJ et al. (2010). Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 304(8):875-880. doi:10.1001/jama.2010.1192 (randomised trial, 86 adults) | Lopez PL, Torrente FM, Ciapponi A et al. (2018). Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 3:CD010840. doi:10.1002/14651858.CD010840.pub2 (systematic review, 14 trials, 700 participants) | Chen JW, Zhu K (2024). Single Exercise for Core Symptoms and Executive Functions in ADHD: A Systematic Review and Meta-Analysis. Journal of Attention Disorders 28(4):399-414. doi:10.1177/10870547231217321 (meta-analysis, 13 studies)
